+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Distribution of Chemokine Receptor Ccr2 and Ccr5 Genotypes and Their Relative Contribution to Human Immunodeficiency Virus Type 1 (Hiv-1) Seroconversion, Early Hiv-1 Rna Concentration in Plasma, and Later Disease Progression



Distribution of Chemokine Receptor Ccr2 and Ccr5 Genotypes and Their Relative Contribution to Human Immunodeficiency Virus Type 1 (Hiv-1) Seroconversion, Early Hiv-1 Rna Concentration in Plasma, and Later Disease Progression



Journal of Virology 76(2): 662-672




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067648667

Download citation: RISBibTeXText

DOI: 10.1128/jvi.76.2.662-672.2002


Related references

Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression. Journal of Virology 76(2): 662-672, 2001

Role of CCR5 chemokine receptor gene in vertical human immunodeficiency virus type 1 transmission and disease progression. Pediatric Infectious Disease Journal 17(9): 847-849, 1998

Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users. Journal of Infectious Diseases 184(10): 1279-1288, 2001

Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy. Journal of Infectious Diseases 184(11): 1402-1411, 2001

Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. Journal of Virology 72(9): 7450-7458, 1998

C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors. Journal of General Virology 91(Pt 12): 2965-2973, 2010

A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Medicine 4(3): 350-353, 1998

Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. Journal of Infectious Diseases 188(10): 1461-1472, 2003

The frequencies of chemokine receptor CCR5 polymorphisms affecting susceptibility to human immunodeficiency virus and the rate of progression to AIDS in Kuwaitis. European Journal of Human Genetics 9(Supplement 1): P0860, 2001

CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy. Aids Research and Human Retroviruses 18(6): 403-412, 2002

Human immunodeficiency virus type 1 disease progression among seropositive intravenous drug users in relation to chemokine receptor and Vitamin-D Receptor gene polymorphisms. European Journal of Human Genetics 9(Supplement 1): P1416, 2001

Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice. Journal of Virology 71(9): 7124-7127, 1997

Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age. Journal of Infectious Diseases 178(4): 1019-1023, 1998

A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1. Journal of Biological Chemistry 274(4): 1905-1913, 1999

Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotype. Journal of Medical Virology 80(2): 192-200, 2007